Importantly, the density of the CD68+CD206+ M2 macrophages significantly increased at the time of PD following cetuximab-based treatment (P = 0.039), whereas it did not consistently change between the tumor pairs of PR/SD (P = 0.700) (Fig. 4B). The gene discussed is MRC1; the disease is neoplasm.